Celestia Higano

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

Susan Halabi, Ethan Basch, P. Kantoff, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research.

Paul Mathew, Daniel George, Christopher Logothetis, 2009, Clinical genitourinary cancer.

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.

Oliver Sartor, Susan Halabi, Lawrence H Schwartz, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer

Hamid Bolouri, Jay Shendure, Min Fang, 2016 .

Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B

Judith Campisi, Lawrence True, P. Nelson, 2012, Nature Medicine.